Results 41 to 50 of about 718 (153)

Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis

open access: yesNeurobiology of Disease, 2008
Juvenile neuronal ceroid lipofuscinosis (JNCL) is an autosomal recessively inherited neurodegenerative disorder that results from mutations in the CLN3 gene.
Martin L. Katz   +3 more
doaj   +1 more source

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology. [PDF]

open access: yesOrphanet J Rare Dis
Background CLN3 disease, also called Juvenile Neuronal Ceroid Lipofuscinosis (JNCL), or Batten disease, is an ultra‑rare, neurodegenerative lysosomal storage disorder generally affecting individuals during the first decade of life.
Mink JW   +18 more
europepmc   +2 more sources

Atypical juvenile neuronal ceroid lipofuscinosis: A report of three cases

open access: yesJournal of Pediatric Neurosciences, 2013
The diagnosis of juvenile neuronal ceroid lipofuscinosis (JNCL) is usually based on age of onset, initial clinical symptoms, clinical progression, and pathologic findings.
Gururaj Setty   +3 more
doaj   +1 more source

El Niño impacts on human‐modified tropical forests: Consequences for dung beetle diversity and associated ecological processes

open access: yesBiotropica, Volume 52, Issue 2, Page 252-262, March 2020., 2020
Abstract Our knowledge of how tropical forest biodiversity and functioning respond to anthropogenic and climate‐associated stressors is limited. Research exploring El Niño impacts are scarce or based on single post‐disturbance assessments, and few studies assess forests previously affected by anthropogenic disturbance.
Filipe M. França   +10 more
wiley   +1 more source

Lysosomal PPT1‐insufficiency is a common pathogenic link between INCL and JNCL

open access: yesThe FASEB Journal, 2020
Neuronal Ceroid Lipofuscinoses (NCLs), also known as Batten disease, constitute a group of the most common inherited childhood neurodegenerative lysosomal storage disorders (LSDs). Even though mutations in >13 different genes cause various NCLs, at the cellular level, all the NCLs ...
Abhilash Puthuvelvippel Appu   +4 more
openaire   +1 more source

TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. [PDF]

open access: yesSci Rep
Mutations in the lysosomal membrane protein CLN3 cause Juvenile Neuronal Ceroid Lipofuscinosis (JNCL). Activation of the lysosomal ion channel TRPML1 has previously been shown to be beneficial in several neurodegenerative disease models.
Wünkhaus D   +13 more
europepmc   +2 more sources

Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis

open access: yesJournal of Pediatric Neurosciences, 2013
We detected a novel CLN1 gene mutation (p.Arg151X, heterogenous) in a 12-year-old boy. Low level of palmitoyl protein thioesterase and granular inclusion pattern in lymphocytes were also consistent with infantile Neuronal ceroid lipofuscinosis (INCL ...
Arif Khan   +4 more
doaj   +1 more source

A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures

open access: yesNeurobiology of Disease, 2011
Juvenile neuronal ceroid lipofuscinosis (JNCL) or Batten disease is an autosomal recessive neurodegenerative disorder of children caused by mutation in CLN3.
Song-Lin Ding   +3 more
doaj   +1 more source

CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events.

open access: yesPLoS ONE, 2014
Juvenile Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL) is a devastating neurodegenerative disease caused by mutations in CLN3, a protein of undefined function.
Mark L Schultz   +4 more
doaj   +1 more source

Näönkuntoutus osana JNCL-lasten toimintakyvyn tukemista Suomessa [PDF]

open access: yes, 2020
JNCL eli Juveniili neuronaalinen lipoidifuskinoosi on perinnöllinen etenevä keskushermoston sairaus. Sairauden eteneminen alkaa tavallisesti 4-6 vuoden iässä, jolloin lapsen näkökyky alkaa äkillisesti heikentyä johtaen lopulta sokeutumiseen.
Touronen, Jani
core  

Home - About - Disclaimer - Privacy